Detalhe da pesquisa
1.
Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer.
Int J Mol Sci
; 21(20)2020 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33086721
2.
Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer.
Int J Mol Sci
; 21(20)2020 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081219
3.
Fatty acid synthase is required for profibrotic TGF-ß signaling.
FASEB J
; 32(7): 3803-3815, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29475397
4.
Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells.
Carcinogenesis
; 39(4): 601-613, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29452350
5.
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.
Mol Oncol
; 18(3): 479-516, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158755
6.
Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.
J Cell Physiol
; 227(11): 3621-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22331587
7.
Fatty acid synthase: a druggable driver of breast cancer brain metastasis.
Expert Opin Ther Targets
; 26(5): 427-444, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545806
8.
Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling.
Am J Cancer Res
; 12(5): 2173-2188, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35693067
9.
Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells.
Cancers (Basel)
; 14(24)2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551699
10.
Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6ß1 drives endocrine resistance in breast cancer cells.
Aging (Albany NY)
; 14(3): 1200-1213, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35148282
11.
Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness.
Am J Cancer Res
; 12(2): 839-851, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35261806
12.
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.
Cancers (Basel)
; 13(5)2021 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33800852
13.
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells.
Cell Death Dis
; 12(11): 977, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675185
14.
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy.
Cancers (Basel)
; 12(7)2020 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32630618
15.
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer.
Aging (Albany NY)
; 12(24): 24671-24692, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335078
16.
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.
Int J Cancer
; 125(9): 2004-13, 2009 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19530242
17.
Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells.
Biochem Biophys Res Commun
; 385(3): 454-9, 2009 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19467222
18.
Plasminogen-induced aggregation of PANC-1 cells requires conversion to plasmin and is inhibited by endogenous plasminogen activator inhibitor-1.
J Cell Physiol
; 216(3): 632-9, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18366077
19.
An easy, rapid and objective mathematical method to identify fatty acid synthase (oncogenic antigen-519) modulators with potential anticancer value.
Clin Transl Oncol
; 10(4): 219-26, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18411195
20.
Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?
Breast Cancer Res
; 9(5): 111, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17983482